Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Garrett Alewine"'
Publikováno v:
Pharmaceutics, Vol 16, Iss 3, p 371 (2024)
Neurofibromatosis Type 1 (NF1) is a common neurogenic condition characterized by heterozygous loss of function mutations in the neurofibromin gene. NF1 patients are susceptible to the development of neurofibromas, including plexiform neurofibromas (p
Externí odkaz:
https://doaj.org/article/4c8e457f923f41c38b1827e9a7fcd4a3
Autor:
Garrett Alewine, Jerrica Knight, Adithya Ghantae, Christina Mamrega, Bashnona Attiah, Robert A. Coover, Cale D. Fahrenholtz
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 7; Pages: 1080
Neurofibromatosis type 1 (NF1) is among the most common neurogenic disorders, characterized by loss of function mutations in the neurofibromin gene (NF1). NF1 patients are extremely susceptible to developing neurofibromas, which can transform into de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abd2268137255a0d4c67a8269be79b37
https://pubmed.ncbi.nlm.nih.gov/35887576
https://pubmed.ncbi.nlm.nih.gov/35887576
Autor:
Garrett Alewine, Adithya Ghantae, Christina Mamrega, Jerrica L. Knight, Bashnona Attiah, Robert A. Coover, Cale D. Fahrenholtz
Publikováno v:
Cancer Research. 82:373-373
Neurofibromatosis type 1 (NF1) is the most common neurogenic disorder affecting 1 in every 3,000 people worldwide. NF1 is defined by heterozygous loss-of-function of the neurofibromin 1 gene (NF1). NF1 patients develop neurofibromas with near complet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb18e84e0939293091264c94f0451a1b
https://doi.org/10.1158/1538-7445.am2022-373
https://doi.org/10.1158/1538-7445.am2022-373